 |
China to Strengthen Pharmaceutical Control
The Chinese legislature is revising the Pharmaceutical Administration Law to strictly control the country's drug market.
At the 17th meeting of the Standing Committee of the National People's Congress today, a hearing was held for the report on the draft revision of the law delivered by Zheng Xiaoyu, director of the State Drug Administration.
Since being implemented on July 1, 1995, the law has played a big role in curbing the making and sale of counterfeit and inferior drugs, Zheng said.
But the law is out of date and needs to be revised to keep up with the times, according to the official.
In his report, the official explained the changes and amendments made in the draft, including the conditions for establishing pharmaceutical manufacturers, quality control over raw materials and products of traditional Chinese herbal drugs.
In This Section
|